Connected Healthcare: The Critical Role of Non-Identified Information

NEW YORK, Dec. 4, 2015 /PRNewswire/ -- The dramatic increase in the amount of digitized health data generated each day brings new possibilities to apply that information to advance research and understanding in our connected healthcare system.

As a global leader in protecting individual patient privacy, IMS Health (NYSE: IMS) uses anonymous healthcare data to deliver critical, real-world disease and treatment insights.

This article excerpt below from CIOStory, written by Murray Aitken, executive director, IMS Institute for Healthcare Informatics looks at the societal value and uses of non-identified health information.

ARTICLE EXCERPT:

Every CIO knows the value and impact that relevant data can have on driving efficiencies, revenue and achieving organization objectives. Perhaps no industry has more to gain from the combination of powerful analytics and meaningful informatics than the healthcare sector.

The opportunity to close the healthcare gap – the difference between today's reality and what is possible from a clinical, patient and economic perspective – remains a real but elusive promise for all health systems.

As CIOs work more closely with privacy officers, information security personnel and overall data governance issues, appropriate management of health information is becoming an increasingly important component of operating an effective health care business. 

To view the entire article as it appears on CIOStory click here:

http://ciostory.com/cxo-perspectives/connected-healthcare-the-critical-role-of-non-identified-information

About the IMS Institute for Healthcare Informatics

The IMS Institute for Healthcare Informatics provides key policy setters and decision makers in the global health sector with unique and transformational insights into healthcare dynamics derived from granular analysis of information. It is a research-driven entity with a worldwide reach that collaborates with external healthcare experts from across academia and the public and private sectors to objectively apply IMS Health's proprietary global information and analytical assets. More information about the IMS Institute can be found at: http://www.theimsinstitute.org.

About IMS Health

IMS Health (NYSE:IMS) is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,500 services experts connect configurable SaaS applications to 10+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company's 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at www.imshealth.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/connected-healthcare-the-critical-role-of-non-identified-information-300188182.html

SOURCE IMS Health

Copyright 2015 PR Newswire